|
1
|
Crozier JA and Perez EA: Perspectives from
the American Society of Clinical Oncology 2014 Conference: Breast
cancer highlights. Future Oncol. 10:1897–1899. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng R, Zeng H, Zhang S, Chen T and Chen
W: National estimates of cancer prevalence in China, 2011. Cancer
Lett. 370:33–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zubeda S, Kaipa PR, Shaik NA, Mohiuddin
MK, Vaidya S, Pavani B, Srinivasulu M, Latha MM and Hasan Q:
Her-2/neu status: A neglected marker of prognostication and
management of breast cancer patients in India. Asian Pac J Cancer
Prev. 14:2231–2235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clifton GT, Mittendorf EA and Peoples GE:
Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
Immunotherapy. 7:1159–1168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Santana AB, Gurgel MS, de Oliveira
Montanari JF, Bonini FM and de Barros-Mazon S: Serum amyloid is
associated with obesity and estrogen receptor-negative tumors in
postmenopausal women with breast cancer. Cancer Epidemiol
Biomarkers Prev. 22:270–274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen T, Brandwein-Gensler M, Hameed O,
Siegal GP and Wei S: Characterization of estrogen
receptor-negative/progesterone receptor-positive breast cancer. Hum
Pathol. 46:1776–1784. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shapochka DO, Zaletok SP and Gnidyuk MI:
Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression
in human breast cancer. Exp Oncol. 34:358–363. 2012.PubMed/NCBI
|
|
8
|
Mashima R, Arimura S, Kajikawa S, Oda H,
Nakae S and Yamanashi Y: Dok adaptors play anti-inflammatory roles
in pulmonary homeostasis. Genes Cells. 18:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miyagaki H, Yamasaki M, Takahashi T,
Kurokawa Y, Miyata H, Nakajima K, Takiguchi S, Fujiwara Y, Mori M
and Doki Y: DOK2 as a marker of poor prognosis of patients with
gastric adenocarcinoma after curative resection. Ann Surg Oncol.
19:1560–1567. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wen X, Zhou M, Guo Y, Zhu Y, Li H, Zhang
L, Yu L, Wang X and Peng X: Expression and significance of DOK2 in
colorectal cancer. Oncol Lett. 9:241–244. 2015.PubMed/NCBI
|
|
11
|
Sun D, Yu F, Ma Y, Zhao R, Chen X, Zhu J,
Zhang CY, Chen J and Zhang J: MicroRNA-31 activates the RAS pathway
and functions as an oncogenic MicroRNA in human colorectal cancer
by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol
Chem. 288:9508–9518. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sharma SB, Lin CC, Farrugia MK, McLaughlin
SL, Ellis EJ, Brundage KM, Salkeni MA and Ruppert JM: MicroRNAs 206
and 21 cooperate to promote RAS-extracellular signal-regulated
kinase signaling by suppressing the translation of RASA1 and
SPRED1. Mol Cell Biol. 34:4143–4164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong B, Liu WW, Nie WJ, Li DF, Xie ZJ, Liu
C, Liu YH, Mei P and Li ZJ: miR-21/RASA1 axis affects malignancy of
colon cancer cells via RAS pathways. World J Gastroenterol.
21:1488–1497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Liu T, Sun Q, Niu M, Jiang Y and
Pang D: Downregulation of Ras GTPase-activating protein 1 is
associated with poor survival of breast invasive ductal carcinoma
patients. Oncol Rep. 33:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fan L, Goss PE and Strasser-Weippl K:
Current status and future projections of breast cancer in Asia.
Breast Care (Basel). 10:372–378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Berger AH, Niki M, Morotti A, Taylor BS,
Socci ND, Viale A, Brennan C, Szoke J, Motoi N, Rothman PB, et al:
Identification of DOK genes as lung tumor suppressors. Nat Genet.
42:216–223. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim MS, Chung NG, Yoo NJ and Lee SH:
Mutational analysis of DOK2 tumor suppressor gene in acute
leukemias. Leuk Res. 35:e87–e88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coppin E, Gelsi-Boyer V, Morelli X,
Cervera N, Murati A, Pandolfi PP, Birnbaum D and Nunès JA:
Mutational analysis of the DOK2 haploinsufficient tumor suppressor
gene in chronic myelomonocytic leukemia (CMML). Leukemia.
29:500–502. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
An CH, Kim MS, Yoo NJ and Lee SH:
Mutational and expressional analysis of a haploinsufficient tumor
suppressor gene DOK2 in gastric and colorectal cancers. APMIS.
119:562–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Berger AH, Chen M, Morotti A, Janas JA,
Niki M, Bronson RT, Taylor BS, Ladanyi M, Van Aelst L, Politi K, et
al: DOK2 inhibits EGFR-mutated lung adenocarcinoma. PLoS One.
8:e795262013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lum E, Vigliotti M, Banerjee N, Cutter N,
Wrzeszczynski KO, Khan S, Kamalakaran S, Levine DA, Dimitrova N and
Lucito R: Loss of DOK2 induces carboplatin resistance in ovarian
cancer via suppression of apoptosis. Gynecol Oncol. 130:369–376.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Figueroa JD, Wallstrom G, Barker
K, Park JG, Demirkan G, Lissowska J, Anderson KS, Qiu J and LaBaer
J: Plasma autoantibodies associated with basal-like breast cancers.
Cancer Epidemiol Biomarkers Prev. 24:1332–1340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vigil D, Cherfils J, Rossman KL and Der
CJ: Ras superfamily GEFs and GAPs: Validated and tractable targets
for cancer therapy? Nat Rev Cancer. 10:842–857. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anand S, Majeti BK, Acevedo LM, Murphy EA,
Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN,
Lapinski PE, et al: MicroRNA-132-mediated loss of p120RasGAP
activates the endothelium to facilitate pathological angiogenesis.
Nat Med. 16:909–914. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pamonsinlapatham P, Hadj-Slimane R,
Lepelletier Y, Allain B, Toccafondi M, Garbay C and Raynaud F:
p120-Ras GTPase activating protein (RasGAP): A multi-interacting
protein in downstream signaling. Biochimie. 91:320–328. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ulger C, Toruner GA, Alkan M, Mohammed M,
Damani S, Kang J, Galante A, Aviv H, Soteropoulos P, Tolias PP, et
al: Comprehensive genome-wide comparison of DNA and RNA level scan
using microarray technology for identification of candidate
cancer-related genes in the HL-60 cell line. Cancer Genet
Cytogenet. 147:28–35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu X, Stern HM, Ge L, O'Brien C, Haydu L,
Honchell CD, Haverty PM, Peters BA, Wu TD, Amler LC, et al: Genetic
alterations and oncogenic pathways associated with breast cancer
subtypes. Mol Cancer Res. 7:511–522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calvisi DF, Ladu S, Conner EA, Seo D,
Hsieh JT, Factor VM, Factor VM and Thorgeirsson SS: Inactivation of
Ras GTPase-activating proteins promotes unrestrained activity of
wild-type Ras in human liver cancer. J Hepatol. 54:311–319. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du C, Weng X, Hu W, Lv Z, Xiao H, Ding C,
Gyabaah OA, Xie H, Zhou L, Wu J and Zheng S: Hypoxia-inducible
miR-182 promotes angiogenesis by targeting RASA1 in hepatocellular
carcinoma. J Exp Clin Cancer Res. 34:672015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Organ SL, Hai J, Radulovich N, Marshall
CB, Leung L, Sasazuki T, Shirasawa S, Zhu CQ, Navab R, Ikura M and
Tsao MS: p120RasGAP is a mediator of rho pathway activation and
tumorigenicity in the DLD1 colorectal cancer cell line. PLoS One.
9:e861032014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun D, Wang C, Long S, Ma Y, Guo Y, Huang
Z, Chen X, Zhang C, Chen J and Zhang J: C/EBP-β-activated
microRNA-223 promotes tumour growth through targeting RASA1 in
human colorectal cancer. Br J Cancer. 112:1491–1500. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu Y, Yang H, Yuan L, Liu G, Zhang C, Hong
M, Liu Y, Zhou M, Chen F and Li X: Overexpression of miR-335
confers cell proliferation and tumour growth to colorectal
carcinoma cells. Mol Cell Biochem. 412:235–245. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu YJ, Xu B and Xia W: Hsa-mir-182
downregulates RASA1 and suppresses lung squamous cell carcinoma
cell proliferation. Clin Lab. 60:155–159. 2014.PubMed/NCBI
|
|
34
|
Liu X, Jia Y, Stoopler MB, Shen Y, Cheng
H, Chen J, Mansukhani M, Koul S, Halmos B and Borczuk AC:
Next-generation sequencing of pulmonary sarcomatoid carcinoma
reveals high frequency of actionable MET gene mutations. J Clin
Oncol. 34:794–802. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sowalsky AG, Xia Z, Wang L, Zhao H, Chen
S, Bubley GJ, Balk SP and Li W: Whole transcriptome sequencing
reveals extensive unspliced mRNA in metastatic castration-resistant
prostate cancer. Mol Cancer Res. 13:98–106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Berndt SI, Wang Z, Yeager M, Alavanja MC,
Albanes D, Amundadottir L, Andriole G, Freeman Beane L, Campa D,
Cancel-Tassin G, et al: Two susceptibility loci identified for
prostate cancer aggressiveness. Nat Commun. 6:68892015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pickering CR, Zhou JH, Lee JJ, Drummond
JA, Peng SA, Saade RE, Tsai KY, Curry JL, Tetzlaff MT, Lai SY, et
al: Mutational landscape of aggressive cutaneous squamous cell
carcinoma. Clin Cancer Res. 20:6582–6592. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Z, Li D, Zhang G, Xiong J, Jie Z, Cheng
H, Cao Y, Jiang M, Lin L, Le Z, et al: Methylation-associated
silencing of MicroRNA-335 contributes tumor cell invasion and
migration by interacting with RASA1 in gastric cancer. Am J Cancer
Res. 4:648–662. 2014.PubMed/NCBI
|
|
39
|
Lubeck BA, Lapinski PE, Oliver JA, Ksionda
O, Parada LF, Zhu Y, Maillard I, Chiang M, Roose J and King PD:
Cutting edge: Codeletion of the Ras GTPase-activating proteins
(RasGAPs) neurofibromin 1 and p120 RasGAP in T cells results in the
development of T cell acute lymphoblastic leukemia. J Immunol.
195:31–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kansal R, Li X, Shen J, Samuel D,
Laningham F, Lee H, Panigrahi GB, Shuen A, Kantarci S, Dorrani N,
et al: An infant with MLH3 variants, FOXG1-duplication and
multiple, benign cranial and spinal tumors: A clinical exome
sequencing study. Genes Chromosomes Cancer. 55:131–142. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rusinek D, Swierniak M, Chmielik E, Kowal
M, Kowalska M, Cyplinska R, Czarniecka A, Piglowski W, Korfanty J,
Chekan M, et al: BRAFV600E-associated gene expression profile:
Early changes in the transcriptome, based on a transgenic mouse
model of papillary thyroid carcinoma. PLoS One. 10:e01436882015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Park C, Ha SY, Kim ST, Kim HC, Heo JS,
Park YS, Lauwers G, Lee J and Kim KM: Identification of the BRAF
V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Oncotarget. 7:4024–4035. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kent OA, Mendell JT and Rottapel R:
Transcriptional regulation of miR-31 by oncogenic KRAS mediates
metastatic phenotypes by repressing RASA1. Mol Cancer Res.
14:267–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mihrshahi R, Barclay AN and Brown MH:
Essential roles for Dok2 and RasGAP in CD200 receptor-mediated
regulation of human myeloid cells. J Immunol. 183:4879–4886. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lapinski PE, Qiao Y, Chang CH and King PD:
A role for p120 RasGAP in thymocyte positive selection and survival
of naive T cells. J Immunol. 187:151–163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Downer EJ, Johnston DG and Lynch MA:
Differential role of Dok1 and Dok2 in TLR2-induced inflammatory
signaling in glia. Mol Cell Neurosci. 56:148–158. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xu C, Wang Z, Cui R, He H, Lin X, Sheng Y
and Zhang H: Co-expression of parathyroid hormone related protein
and TGF-beta in breast cancer predicts poor survival outcome. BMC
Cancer. 15:9252015. View Article : Google Scholar : PubMed/NCBI
|
